December 2020 in “Our Dermatology Online” This study found that there was a significant discrepancy between histopathological examination and clinical diagnosis in alopecia cases, while vitamin D levels were not significantly associated with alopecia.
October 2020 in “Our Dermatology Online” This case report highlights how chronic bacterial folliculitis may contribute to persistent inflammation in lichen simplex chronicus and emphasizes the value of DIF and IHC in diagnosing obscure cases.
October 2020 in “Our Dermatology Online” This report presents two cases where dermatologists identified internal malignancies—small cell lung cancer and stage IIB cervical cancer—through paraneoplastic skin manifestations.
February 2020 in “Our Dermatology Online” A synthetic drug and a South American herb may help treat alopecia areata in Chinese men.
January 2020 in “Nasza Dermatologia Online” A mixture of Dijon mustard, turmeric powder, and linseed oil can effectively treat alopecia barbae.
March 2019 in “Nasza Dermatologia Online” This case report describes a 52-year-old woman with a rare combination of pemphigus vulgaris and pemphigus foliaceus on the scalp, initially misdiagnosed as psoriasis, who achieved clinical remission and hair regrowth with corticosteroid treatment.
March 2019 in “Our Dermatology Online” A woman with severe hair loss regrew mostly white hair after treatment.
January 2019 in “Our Dermatology Online” This study found that the incidence of anterolateral leg alopecia among men aged 36-52 may be higher than previously reported.
July 2018 in “Nasza Dermatologia Online” The authors report two clinical cases of scarring alopecia in a mother and daughter, suggesting a potential link between frontal fibrosing alopecia and ulerythema ophryogenes.
July 2018 in “Our Dermatology Online” In this study, researchers examined the under-studied mechanisms behind specific dermatological phenomena such as co-localization, Wolf's isotopic phenomenon, Koebner's isomorphic phenomenon, and the recently described Renbök phenomenon, noting that only a few cases have been reported so far.
April 2018 in “Nasza Dermatologia Online” This case report describes an 8-year-old child with Down's syndrome who presented with eruptive syringomas on the face and hand.
January 2018 in “Our Dermatology Online” This case report describes a carpenter who presented with contact dermatitis and trichopathy with whitish nodules in the axillary hair.
April 2017 in “Our Dermatology Online” This study explored how septuagenarians and octogenarians responded hedonically to natural cosmetics that were marketed as making them feel younger and more attractive, using a simple satisfaction questionnaire.
April 2017 in “Our Dermatology Online” This case study identified a 22-year-old patient with multiple autoimmune syndrome type 3, involving lupus erythematosus, autoimmune thyroiditis, alopecia areata, and vitiligo.
January 2017 in “Nasza Dermatologia Online” This study found that both new and old formulas of DCP for treating alopecia areata resulted in similar hair regrowth, but tolerance was significantly better with DCP in isopropanol.
April 2015 in “Our Dermatology Online” This report presents a case of acrodermatitis enteropathica in a 22-year-old female, highlighting the absence of underlying comorbid conditions.
January 2015 in “Nasza Dermatologia Online” This case report describes an eight-year-old Kashmiri boy diagnosed with monilethrix, a rare genetic hair disorder, characterized by a beaded appearance and fragility of the hair shaft.
January 2015 in “Our Dermatology Online” This study found that intralesional triamcinolone was the most effective treatment for achieving over 50% hair regrowth in alopecia areata patients, especially those with single patches.
October 2014 in “Our Dermatology Online” This study found that mesotherapy with dutasteride effectively reduced or stopped hair loss and promoted new hair growth in males with androgenetic alopecia.
July 2014 in “Nasza Dermatologia Online” This article discusses various methods of facial enhancement, such as botulinum toxin and fillers, and emphasizes their temporary nature but reports no new clinical results.
July 2013 in “Our Dermatology Online” In this case study, an 11-year-old boy with extensive alopecia areata showed 80% hair regrowth after six months of treatment with methylprednisolone despite initial lack of response to topical therapies.
July 2013 in “Our Dermatology Online” In this study, minoxidil 2% solution was more effective than tacrolimus 0.1% ointment for promoting hair regrowth in mild to moderate patchy alopecia areata.
October 2022 in “Our Dermatology Online” In this study, researchers compared the effectiveness of a tonic containing Capixyl, Procapil, and rosemary extract with 2% minoxidil in reducing hair loss and promoting hair growth in male participants over a 24-week period.
June 2022 in “Our Dermatology Online” In this study, researchers found that trichoscopy helps detect early signs of female-pattern hair loss before it is visible, highlighting its importance for monitoring and managing the condition.
October 2019 in “Our Dermatology Online” In this study, researchers reported that androgenetic alopecia is associated with significantly decreased quality of life, particularly impacting younger patients and those with severe or long-standing hair loss.
January 2018 in “Our Dermatology Online” This review summarizes the use of injectable dutasteride mesotherapy for androgenic alopecia and reports improved hair growth when combined with other substances, but highlights the need for further studies to establish long-term protocols.
28 citations
,
October 2014 in “Pharmaceutical Biology” This study documented 80 plant species used as traditional cosmetics in parts of South West Nigeria, preserving orally transmitted information on these practices.
1 citations
,
January 2013 in “INTAS POLIVET” In this case study, a Labrador dog diagnosed with hypothyroidism and treated with Thyroxine sodium, along with other supportive therapies, recovered completely from a generalized skin infection and alopecia within three months.
1 citations
,
January 2010 in “SRX Pharmacology” This study found that bupropion SR may improve symptoms in female trichotillomania patients who did not respond to SSRIs, with benefits maintained through a 16-month follow-up.
February 2025 in “PubMed” This study evaluated an AI-driven system for personalizing non-medicated hair loss treatments in women, showing significant improvements in hair growth, shedding, texture, and scalp health over 24 weeks, with no adverse effects reported.